Related references
Note: Only part of the references are listed.Nitroglycerin Plus Whole Intracranial Radiation Therapy for Brain Metastases in Patients With Non-Small Cell Lung Cancer: A Randomized
Oscar Arrieta et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2023)
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline
Michael A. Vogelbaum et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Efficacy and Safety of Combined Brain Radiotherapy and Immunotherapy in Non-Small-Cell Lung Cancer With Brain Metastases: A Systematic Review and Meta-Analysis
Yin Yang et al.
CLINICAL LUNG CANCER (2022)
Intracranial complete response for non-small-cell lung cancer patient with negative PD-L1 expression of the lung using nivolumab
Rui Kitadai et al.
CANCER REPORTS (2022)
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial
Luis Paz-Ares et al.
LANCET ONCOLOGY (2021)
Whole-brain radiotherapy with and without concurrent erlotinib in NSCLC with brain metastases: a multicenter, open-label, randomized, controlled phase III trial
Zhenzhou Yang et al.
NEURO-ONCOLOGY (2021)
A Bayesian network meta-analysis regarding the comparative efficacy of therapeutics for ALK-positive, brain metastatic non-small cell lung cancer
Binghao Zhao et al.
PHARMACOLOGICAL RESEARCH (2021)
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial
Ahmet Sezer et al.
LANCET (2021)
Efficacy and safety of treatment modalities across EGFR selected/unselected populations with non-small cell lung cancer and brain metastases: A systematic review and Bayesian network meta-analysis
Lihui Liu et al.
LUNG CANCER (2021)
Anti-PD1 Therapy Plus Whole-Brain Radiation Therapy May Prolong PFS in Selected Non-Small Cell Lung Cancer Patients with Brain Metastases: A Retrospective Study
Muhammad Khan et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)
Radiation Therapy for Brain Metastases: A Systematic Review
Adam Garsa et al.
PRACTICAL RADIATION ONCOLOGY (2021)
Current approaches to the management of brain metastases
John H. Suh et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Use of Programmed Death Receptor-1 and/or Programmed Death Ligand 1 Inhibitors for the Treatment of Brain Metastasis of Lung Cancer
Shiqiang Wang et al.
ONCOTARGETS AND THERAPY (2020)
PD-1/PD-L1 Blockers in NSCLC Brain Metastases: Challenging Paradigms and Clinical Practice
Inaki Eguren-Santamaria et al.
CLINICAL CANCER RESEARCH (2020)
Non-small-cell lung cancer brain metastases and PD-(L)1 immune checkpoint inhibitors
Fabrice Barlesi et al.
LANCET ONCOLOGY (2020)
EGFR Polymorphism and Survival of NSCLC Patients Treated with TKIs: A Systematic Review and Meta-Analysis
Vladimir Jurisic et al.
JOURNAL OF ONCOLOGY (2020)
Feasibility and safety of PD-1/L1 inhibitors for non-small cell lung cancer in front-line treatment: a Bayesian network meta-analysis
Hengrui Liang et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Efficacy and safety of therapies for EGFR-mutant non-small cell lung cancer with brain metastasis: an evidence-based Bayesian network pooled study of multivariable survival analyses
Binghao Zhao et al.
AGING-US (2020)
Comparative analysis of first-line treatment regimens for advanced EGFR-mutant non-small cell lung cancer patients with stable brain metastases
Lu Dai et al.
ANNALS OF PALLIATIVE MEDICINE (2020)
Management of brain metastases according to molecular subtypes
Riccardo Soffietti et al.
NATURE REVIEWS NEUROLOGY (2020)
Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial
Bart J. T. Reymen et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2020)
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial
Yi-Long Wu et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Atezolizumab in patients with advanced non -small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study
Shirish M. Gadgeel et al.
LUNG CANCER (2019)
Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer
Lucio Crino et al.
LUNG CANCER (2019)
PD-L1 Expression of Lung Cancer Cells, Unlike Infiltrating Immune Cells, Is Stable and Unaffected by Therapy During Brain Metastasis
Vanda Teglasi et al.
CLINICAL LUNG CANCER (2019)
Initial SRS for Patients With 5 to 15 Brain Metastases: Results of a Multi-Institutional Experience
Ryan T. Hughes et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial
Howard West et al.
LANCET ONCOLOGY (2019)
Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer A Review
Kathryn C. Arbour et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer
M. D. Hellmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
1483PDPembrolizumab (pembro) plus platinum-based chemotherapy (chemo) in NSCLC with brain metastases: Pooled analysis of KEYNOTE-021, 189, and 407
S F Powell et al.
ANNALS OF ONCOLOGY (2019)
Comparative efficacy and safety of immunotherapies targeting the PD-1/PD-L1 pathway for previously treated advanced non-small cell lung cancer: A Bayesian network meta-analysis
Abdulaali R. Almutairi et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Combination of radiotherapy and immunotherapy for brain metastases: A systematic review and meta-analysis
Fausto Petrelli et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Chemotherapy in the Management of Adults With Newly Diagnosed Metastatic Brain Tumors
Jonathan H. Sherman et al.
NEUROSURGERY (2019)
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Whole Brain Radiation Therapy in Adults With Newly Diagnosed Metastatic Brain Tumors
Laurie E. Gaspar et al.
NEUROSURGERY (2019)
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Use of Stereotactic Radiosurgery in the Treatment of Adults With Metastatic Brain Tumors
Jerome J. Graber et al.
NEUROSURGERY (2019)
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Emerging and Investigational Therapties for the Treatment of Adults With Metastatic Brain Tumors
J. Bradley Elder et al.
NEUROSURGERY (2019)
Brain metastases
Achal Singh Achrol et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases
E. E. Vokes et al.
ANNALS OF ONCOLOGY (2018)
Brain metastases in non-small-cell lung cancer: are tyrosine kinase inhibitors and checkpoint inhibitors now viable options?
S. Morin-Ben Abdallah et al.
CURRENT ONCOLOGY (2018)
Whole-Brain Radiotherapy for Brain Metastases: Evolution or Revolution?
Paul D. Brown et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study
Georgina V. Long et al.
LANCET ONCOLOGY (2018)
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
L. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking
David Taggart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Intensity-modulated radiation therapy combined with concomitant temozolomide for brain metastases from lung adenocarcinoma
Jinli Li et al.
ONCOLOGY LETTERS (2018)
Meta-analysis of whole-brain radiotherapy plus temozolomide compared with whole-brain radiotherapy for the treatment of brain metastases from non-small-cell lung cancer
Yong Xin et al.
CANCER MEDICINE (2018)
Epidermal Growth Factor Receptor Gene in Non-Small-Cell Lung Cancer: The Importance of Promoter Polymorphism Investigation
Vladimir Jurisic et al.
ANALYTICAL CELLULAR PATHOLOGY (2018)
FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1-Selected Patients With NSCLC
David R. Spigel et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Randomized, Placebo-Controlled, Phase II Study of Veliparib in Combination with Carboplatin and Paclitaxel for Advanced/Metastatic Non-Small Cell Lung Cancer
Suresh S. Ramalingam et al.
CLINICAL CANCER RESEARCH (2017)
Veliparib in combination with whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer: results of a randomized, global, placebo-controlled study
Pierre Chabot et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis
Roshan S. Prabhu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis
Jingru Tian et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Achim Rittmeyer et al.
LANCET (2017)
Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)
Riccardo Soffietti et al.
NEURO-ONCOLOGY (2017)
Lung cancer-associated brain metastasis: Molecular mechanisms and therapeutic options
Meysam Yousefi et al.
CELLULAR ONCOLOGY (2017)
Phase II Study of the Efficacy and Safety of High-dose Pemetrexed in Combination with Cisplatin Versus Temozolomide for the Treatment of Non-small Cell Lung Cancer with Brain Metastases
Qiaowei He et al.
ANTICANCER RESEARCH (2017)
The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases
Xia Deng et al.
BMC CANCER (2017)
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases A Randomized Clinical Trial
Paul D. Brown et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Brain Metastases from NSCLC: Radiation Therapy in the Era of Targeted Therapies
Jonathan Khalifa et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial
Paula Mulvenna et al.
LANCET (2016)
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
Louis Fehrenbacher et al.
LANCET (2016)
Frequencies of EGFR single nucleotide polymorphisms in non-small cell lung cancer patients and healthy individuals in the Republic of Serbia: a preliminary study
Jasmina Obradovic et al.
TUMOR BIOLOGY (2016)
Effects of Temozolomide and Radiotherapy on Brain Metastatic Tumor: A Systematic Review and Meta-Analysis
Wenhua Ma et al.
WORLD NEUROSURGERY (2016)
Biomarkers for the Clinical Use of PD-1/PD-L1 Inhibitors in Non-Small-Cell Lung Cancer A Review
Adrian G. Sacher et al.
JAMA ONCOLOGY (2016)
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
Brian Hutton et al.
ANNALS OF INTERNAL MEDICINE (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Efficacy of Surgical Treatment for Brain Metastasis in Patients with Non-Small Cell Lung Cancer
Sang Young Kim et al.
YONSEI MEDICAL JOURNAL (2015)
Comparison Between Surgical Resection and Stereotactic Radiosurgery in Patients with a Single Brain Metastasis from Non-Small Cell Lung Cancer
Emilie Bougie et al.
WORLD NEUROSURGERY (2015)
A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancer
S. H. Lim et al.
ANNALS OF ONCOLOGY (2015)
Comparison of Gefitinib Versus VMP in the Combination with Radiotherapy for Multiple Brain Metastases from Non-small Cell Lung Cancer
Feng Wang et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2015)
Whole brain radiation therapy followed by intensity-modulated boosting treatment combined with concomitant temozolomide for brain metastases from non-small-cell lung cancer
Q. Wang et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2014)
Study on Lung Cancer Cells Expressing VEGFR2 and the Impact on the Effect of RHES Combined With Radiotherapy in the Treatment of Brain Metastases
Xiao-dong Jiang et al.
CLINICAL LUNG CANCER (2014)
Randomized Trial of Erlotinib Plus Whole-Brain Radiotherapy for NSCLC Patients With Multiple Brain Metastases
Siow Ming Lee et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study
Masaaki Yamamoto et al.
LANCET ONCOLOGY (2014)
Phase II study. Concurrent chemotherapy and radiotherapy with nitroglycerin in locally advanced non-small cell lung cancer
Oscar Arrieta et al.
RADIOTHERAPY AND ONCOLOGY (2014)
A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320
Paul W. Sperduto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Temozolomide added to whole brain radiotherapy in patients with multiple brain metastases of non-small-cell lung cancer: a multicentric Austrian phase II study
Marco Ronald Hassler et al.
WIENER KLINISCHE WOCHENSCHRIFT (2013)
Whole Brain Radiotherapy Plus Chemotherapy in the Treatment of Brain Metastases from Lung Cancer: A Metaanalysis of 19 Randomized Controlled Trails
Wen-Jing Liu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)
Gianfranco A. Pesce et al.
EUROPEAN JOURNAL OF CANCER (2012)
A placebo-controlled, randomized phase II study of maintenance enzastaurin following whole brain radiation therapy in the treatment of brain metastases from lung cancer
Bjorn H. Gronberg et al.
LUNG CANCER (2012)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Paclitaxel-Carboplatin Alone or with Endostar for Advanced Non-small Cell Lung Cancer
Baohui Han et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Whole-Brain Radiation Therapy Plus Concomitant Temozolomide for the Treatment of Brain Metastases From Non-Small-Cell Lung Cancer: A Randomized, Open-Label Phase II Study
Daniel Chua et al.
CLINICAL LUNG CANCER (2010)
The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
Minesh P. Mehta et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Randomized, Phase II Trial of Pemetrexed and Carboplatin with or without Enzastaurin versus Docetaxel and Carboplatin as First-Line Treatment of Patients with Stage IIIB/IV Non-small Cell Lung Cancer
Mark A. Socinski et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer
Eunice L. Kwak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases:: a GLOT-GFPC study
A. B. Cortot et al.
ANNALS OF ONCOLOGY (2006)
Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancer
H Yasuda et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: Phase II study
CG Giorgio et al.
LUNG CANCER (2005)
Therapeutic management of brain metastasis
EC Kaal et al.
LANCET NEUROLOGY (2005)
A randomised phase III study of palliative radiation with concomitant carboplatin for brain metastases from non-small cell carcinoma of the lung
M Guerrieri et al.
LUNG CANCER (2004)
The pathogenesis and treatment of brain metastases: a comprehensive review
A Tosoni et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2004)
Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases: a phase II study of the EORTC Lung Cancer Group (08965)
R Dziadziuszko et al.
EUROPEAN JOURNAL OF CANCER (2003)
Share Paper
